These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1693308)

  • 21. [Recombinant (IFN-alpha 2b) therapy in hairy cell leukemia].
    Schwarzmeier JD; Wagner L; Prischl F; Schwabe M; Lion T; Micksche M; Köller U; Bernhart M; Fritz O; Seewann HL
    Klin Wochenschr; 1987 Jul; 65(14):699-705. PubMed ID: 3114550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia.
    Huber C; Aulitzky W; Tilg H; von Lüttichau I; Troppmair J; Nachbauer K; Gastl G
    Leukemia; 1987 Apr; 1(4):355-7. PubMed ID: 3669762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The alpha 2 (r) interferon in the treatment of hairy cell leukemia: progressive report of 25 cases.
    Mandelli F; Cafolla A; Annino L; Amadori S; Gentile A; Bianco P; Dianzani F
    J Biol Regul Homeost Agents; 1987; 1(4):177-82. PubMed ID: 3332545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphological and immunological changes of hairy cell leukemia during alpha-2-interferon therapy.
    Fridrik MA; Wahl G; Herbinger W; Schützenberger W; Gastl G; Huber C; Krönke M; Höpfel I
    Blut; 1989 May; 58(5):261-4. PubMed ID: 2720174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
    Gamliel H; Brownstein BH; Gurfel D; Wu SH; Rosner MC; Golomb HM
    Cancer Res; 1990 Jul; 50(13):4111-20. PubMed ID: 2354460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha interferon production in patients with hairy cell leukemia: correlations with disease activity and remission status.
    Lepe-Zuniga JL; Quesada JR; Baron S; Reuben J; Gutterman JU
    Hematol Pathol; 1987; 1(3):157-65. PubMed ID: 3150846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia.
    Golomb HM; Fefer A; Golde DW; Ozer H; Portlock C; Silber R; Rappeport J; Ratain MJ; Thompson J; Bonnem EM
    Semin Oncol; 1987 Jun; 14(2 Suppl 2):13-7. PubMed ID: 3589701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different antitumor mechanisms of interferon-alpha in the treatment of hairy cell leukemia and renal cell cancer.
    Porzsolt F; Digel W; Jacobsen H; Mittnacht S; Kirchner H; Heimpel H
    Cancer; 1988 Jan; 61(2):288-93. PubMed ID: 3334965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients.
    Sainati L; Matutes E; Mulligan S; de Oliveira MP; Rani S; Lampert IA; Catovsky D
    Blood; 1990 Jul; 76(1):157-62. PubMed ID: 2364167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrastructural, immunologic and clinical follow-up of five patients with HCL treated with interferon (IFN) for more than three years.
    Mantovani G; Astara G; Curreli L; Lai P; Turnu E; Locci F; Lantini MS; Cossu M; Riva A; Del Giacco GS
    Haematologica; 1992; 77(4):326-35. PubMed ID: 1427443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mid-term observations on the efficacy of alpha-interferon in hairy cell leukemia and status of the interferon system of patients in remission.
    Quesada JR; Lepe-Zuniga JL; Gutterman JU
    Leukemia; 1987 Apr; 1(4):317-9. PubMed ID: 3669753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematologic and immunologic changes in hairy cell leukemia patients treated with alpha interferon.
    Turhan AG; Eaves CJ; Connors JM; Eaves AC; Karim KA; Silver KB
    J Biol Regul Homeost Agents; 1988; 2(4):157-65. PubMed ID: 2907963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hairy cells possess more interferon receptors than other lymphoid cell types.
    Dadmarz R; Evans T; Secher D; Marshall N; Cawley JC
    Leukemia; 1987 Apr; 1(4):357-61. PubMed ID: 2959825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hairy cell leukemia in Japanese patients: a study with monoclonal antibodies.
    Katayama I; Hirashima K; Maruyama K; Hoshino S; Abe T; Furusawa S; Iguchi Y
    Leukemia; 1987 Apr; 1(4):301-5. PubMed ID: 3118108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hairy-cell leukemia. Morphologic, cytochemical, and immunologic features.
    Paoletti M; Bitter MA; Vardiman JW
    Clin Lab Med; 1988 Mar; 8(1):179-95. PubMed ID: 3282758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cells.
    Billard C; Sigaux F; Castaigne S; Valensi F; Flandrin G; Degos L; Falcoff E; Aguet M
    Blood; 1986 Mar; 67(3):821-6. PubMed ID: 2936410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of interferon antibodies during prolonged continuous interferon-alpha 2a therapy in hairy cell leukemia.
    Steis RG; Smith JW; Urba WJ; Venzon DJ; Longo DL; Barney R; Evans LM; Itri LM; Ewel CH
    Blood; 1991 Feb; 77(4):792-8. PubMed ID: 1704264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables.
    Ratain MJ; Golomb HM; Vardiman JW; Westbrook CA; Barker C; Hooberman A; Bitter MA; Daly K
    J Clin Oncol; 1988 Nov; 6(11):1714-21. PubMed ID: 3054003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
    Gastl G; Werter M; De Pauw B; Nerl C; Aulitzky W; von Lüttichau I; Tilg H; Thaler J; Lang A; Abbrederis K
    Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained long-term remissions with weekly interferon maintenance therapy in hairy cell leukemia.
    Ramakrishna R; Manoharan A
    Asia Pac J Clin Oncol; 2010 Sep; 6(3):210-2. PubMed ID: 20887503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.